What governance-related experience does HCAC’s new director Stephanie Wen bring?

Stephanie Wen brings significant corporate governance and regulatory experience, having advised listed companies and multinational organizations on governance frameworks, cross-border deals, and regulatory compliance. Her background includes overseeing legal and governance matters for an ASX-listed parent company and its international mining operations.

Hall Chadwick Acquisition adds new board director

Q: What prior roles has HCAC director Stephanie Wen held before joining the board?

Before joining the HCAC board, Stephanie Wen served as General Counsel and Company Secretary at ASX-listed Kingsgate Consolidated Limited and held senior legal roles at Cover-More Group and Swiss Re Group. She also previously served as a non-executive director of ASX-listed Quantum Health Group Limited.

Hall Chadwick Acquisition Corp. reported that its board appointed Stephanie Wei-Ni Wen, age 48, as a director effective June 24, 2026.

Filing Impact

(High)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Hall Chadwick Acquisition Corp. reported that its board appointed Stephanie Wei-Ni Wen, age 48, as a director effective June 24, 2026. She brings over 15 years of experience advising listed companies and multinational groups on corporate governance, cross-border transactions and regulatory matters across Australia and the Asia-Pacific region.

Ms. Wen has served as General Counsel and Company Secretary of ASX-listed Kingsgate Consolidated Limited and previously held senior legal roles at Cover-More Group and Swiss Re Group. She also has prior non-executive director experience with an ASX-listed company and is expected to enter into the company’s standard indemnification agreement for directors and officers.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Appointment effective date: June 24, 2026 Director age: 48 years Professional experience: Over 15 years +3 more

6 metrics

Appointment effective date June 24, 2026 Date Stephanie Wei-Ni Wen commenced as director

Director age 48 years Age of Stephanie Wei-Ni Wen at appointment

Professional experience Over 15 years Experience advising listed companies and multinationals

Kingsgate tenure Aug 2023–Mar 2026 General Counsel and Company Secretary at Kingsgate Consolidated Limited

Swiss Re tenure Jul 2019–Jun 2023 Senior legal role at Swiss Re Group

Quantum Health directorship Sep 2021–Apr 2022 Non-executive director of Quantum Health Group Limited

Key Terms

emerging growth company, indemnification agreement, non-executive director, principal executive offices, +1 more

5 terms

emerging growth company regulatory

"Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

indemnification agreement regulatory

"expected to enter into the Company’s standard form of indemnification agreement"

An indemnification agreement is a contract in which one party promises to cover losses, costs, or legal claims that another party might face, acting like a tailored safety net or private insurance policy. For investors, it matters because such agreements shift potential financial risk away from a company or its officers and onto the indemnifier, which can affect a company’s future liabilities, cash flow and how risky the investment appears during deal-making or litigation.

non-executive director financial

"Wen previously served as a non-executive director of ASX-listed Quantum Health Group Limited"

A non-executive director is a member of a company’s board who does not work for the company day-to-day but provides independent oversight, strategic guidance and checks on management. For investors, they matter because they act like an impartial referee or outside advisor, helping ensure decisions protect shareholder interests, reduce risks of poor governance, and add credibility to financial reporting and long-term strategy.

principal executive offices regulatory

"(Address of principal executive offices)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Hall Chadwick Acquisition Corp. (HCAC) announce in this 8-K filing?

Hall Chadwick Acquisition Corp. announced the appointment of Stephanie Wei-Ni Wen as a director effective June 24, 2026. The filing highlights her extensive legal, transactional, and governance experience across Australia and the Asia-Pacific region supporting listed companies and multinational organizations.

Who is Stephanie Wei-Ni Wen, the new director at Hall Chadwick Acquisition Corp. (HCAC)?

Stephanie Wei-Ni Wen is a legal and governance professional with over 15 years’ experience advising listed companies and multinationals. She has worked on corporate governance, cross-border transactions, and regulatory matters across Australia and Asia-Pacific, particularly with mineral exploration and production companies.

What prior roles has HCAC director Stephanie Wen held before joining the board?

Before joining the HCAC board, Stephanie Wen served as General Counsel and Company Secretary at ASX-listed Kingsgate Consolidated Limited and held senior legal roles at Cover-More Group and Swiss Re Group. She also previously served as a non-executive director of ASX-listed Quantum Health Group Limited.

Will Stephanie Wen enter into any specific agreement with Hall Chadwick Acquisition Corp. (HCAC)?

In connection with her appointment, Stephanie Wen is expected to enter into HCAC’s standard indemnification agreement for directors and officers. Such agreements generally protect directors against certain liabilities incurred while performing their board duties, subject to applicable law and company policies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/26/2026 - 05:14 PM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 24, 2026

HALL CHADWICK ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

Cayman Islands		001-42962		00-0000000N/A
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(I.R.S. Employer Identification Number)

1 North Bridge Road

#18-06 High Street Centre

Singapore

179094

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: +65-90882642

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one Share Right	HCACU	The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share	HCAC	The Nasdaq Stock Market LLC
Share Rights, each right entitling the holder to receive one tenth (1/10) of a Class A ordinary share	HCACR	The Nasdaq Stock Market LLC

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 24, 2026, the board of directors (the “Board”) of Hall Chadwick Acquisition Corp. (the “Company”) appointed Ms. Stephanie Wei-Ni Wen, age 48, to serve as a director of the Company commencing on June 24, 2026. The Board believes that Ms. Wen’s extensive transactional and legal experience advising mineral exploration and mineral production companies qualifies her to serve on the Board.

Ms. Wen has over 15 years’ experience advising listed companies and multinational organizations on corporate governance, cross-border transactions and regulatory matters across Australia and the Asia-Pacific region. She most recently served as General Counsel and Company Secretary of ASX-listed Kingsgate Consolidated Limited from August 2023 to March 2026, where she advised on legal and governance matters relating to the company’s Australian listed parent and its mining operations in Thailand. From August 2018 to June 2019 and July 2019 to June 2023, Ms. Wen held senior legal roles with Cover-More Group and Swiss Re Group, respectively. Prior to that, Ms. Wen practiced corporate law in various legal roles across Australia and Asia. Ms. Wen previously served as a non-executive director of ASX-listed Quantum Health Group Limited from September 2021 to April 2022. She holds Bachelor of Laws and Bachelor of Commerce (Accounting) degrees from the University of New South Wales and a Master of International Affairs from Columbia University.

In connection with her appointment, Ms. Wen is expected to enter into the Company’s standard form of indemnification agreement for directors and officers.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 26, 2026	HALL CHADWICK ACQUISITION CORP.

	By:	/s/ Aaron Dominish
	Name:	Aaron Dominish
	Title:	Chief Financial Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents